Cite Filings / IRD / 0001213900-22-027670
Feed Companies Filings Check
Sign in
SC 13G

Amended Statement of Ownership

Opus Genetics, Inc. · Filed 2022-05-17 · Acc 0001213900-22-027670

Documents 1

  • SC 13G Amended Statement of Ownership , ea160048-13grich_ocuphire.htm

Around this filing

  • 2022-05-24 4 Director bought 5,000 shares at $1.99 ($9,950)
  • 2022-05-23 4 President and CEO bought 25,000 shares at an average $2.05 ($51,179)
  • 2022-05-19 8-K Regulation FD disclosure · Other events
  • 2022-05-17 SC 13G Amended Statement of Ownership
  • 2022-05-13 10-Q Quarterly Report
  • 2022-05-13 8-K Results of operations
  • 2021-03-26 SC 13G Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Caligan Partners LP 6.2%
  2. 2026-11-16 SCHEDULE 13G · Boxer Capital Management, LLC 5.4%
  3. 2026-11-16 SCHEDULE 13G · Cormorant Asset Management, LP 6.61%
  4. 2026-11-16 SCHEDULE 13G/A · BALYASNY ASSET MANAGEMENT L.P. 7.36%
Loading ea160048-13grich_ocuphire.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…